Cranston Lynda Sarah 4
4 · DelMar Pharmaceuticals, Inc. · Filed Oct 2, 2017
Insider Transaction Report
Form 4
Cranston Lynda Sarah
Director
Transactions
- Other
Common Stock
2017-09-29$3.20/sh+71$227→ 2,486 total(indirect: Note)
Footnotes (2)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
- [F2]Shares are held by J.G. Cranston & Associates, Inc.